Medivie Therapeutic (Israel) Market Value

MDVI Stock  ILA 67.00  1.50  2.19%   
Medivie Therapeutic's market value is the price at which a share of Medivie Therapeutic trades on a public exchange. It measures the collective expectations of Medivie Therapeutic investors about its performance. Medivie Therapeutic is trading at 67.00 as of the 28th of March 2024, a -2.19 percent decrease since the beginning of the trading day. The stock's open price was 68.5.
With this module, you can estimate the performance of a buy and hold strategy of Medivie Therapeutic and determine expected loss or profit from investing in Medivie Therapeutic over a given investment horizon. Check out Medivie Therapeutic Correlation, Medivie Therapeutic Volatility and Medivie Therapeutic Alpha and Beta module to complement your research on Medivie Therapeutic.
Symbol

Please note, there is a significant difference between Medivie Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medivie Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medivie Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medivie Therapeutic 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medivie Therapeutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medivie Therapeutic.
0.00
04/08/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
03/28/2024
0.00
If you would invest  0.00  in Medivie Therapeutic on April 8, 2022 and sell it all today you would earn a total of 0.00 from holding Medivie Therapeutic or generate 0.0% return on investment in Medivie Therapeutic over 720 days. Medivie Therapeutic is related to or competes with Magic Software, Amot Investments, YD More, Petrochemical, Azorim Investment, and Netz Hotels. Medivie Therapeutic Limited develops and markets dental devices More

Medivie Therapeutic Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medivie Therapeutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medivie Therapeutic upside and downside potential and time the market with a certain degree of confidence.

Medivie Therapeutic Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Medivie Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medivie Therapeutic's standard deviation. In reality, there are many statistical measures that can use Medivie Therapeutic historical prices to predict the future Medivie Therapeutic's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medivie Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
61.8267.0072.18
Details
Intrinsic
Valuation
LowRealHigh
54.1759.3573.70
Details
Naive
Forecast
LowNextHigh
53.5558.7363.91
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
66.5167.7368.96
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medivie Therapeutic. Your research has to be compared to or analyzed against Medivie Therapeutic's peers to derive any actionable benefits. When done correctly, Medivie Therapeutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medivie Therapeutic.

Medivie Therapeutic Backtested Returns

Medivie Therapeutic has Sharpe Ratio of -0.0128, which conveys that the firm had a -0.0128% return per unit of risk over the last 3 months. Medivie Therapeutic exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medivie Therapeutic's Risk Adjusted Performance of 0.0126, mean deviation of 3.95, and Downside Deviation of 5.58 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -1.05, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Medivie Therapeutic are expected to decrease slowly. On the other hand, during market turmoil, Medivie Therapeutic is expected to outperform it slightly. Medivie Therapeutic has an expected return of -0.0662%. Please make sure to verify Medivie Therapeutic semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to decide if Medivie Therapeutic performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.38  

Below average predictability

Medivie Therapeutic has below average predictability. Overlapping area represents the amount of predictability between Medivie Therapeutic time series from 8th of April 2022 to 3rd of April 2023 and 3rd of April 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medivie Therapeutic price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Medivie Therapeutic price fluctuation can be explain by its past prices.
Correlation Coefficient0.38
Spearman Rank Test0.6
Residual Average0.0
Price Variance409.92

Medivie Therapeutic lagged returns against current returns

Autocorrelation, which is Medivie Therapeutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medivie Therapeutic's stock expected returns. We can calculate the autocorrelation of Medivie Therapeutic returns to help us make a trade decision. For example, suppose you find that Medivie Therapeutic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Medivie Therapeutic regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medivie Therapeutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medivie Therapeutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medivie Therapeutic stock over time.
   Current vs Lagged Prices   
       Timeline  

Medivie Therapeutic Lagged Returns

When evaluating Medivie Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medivie Therapeutic stock have on its future price. Medivie Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medivie Therapeutic autocorrelation shows the relationship between Medivie Therapeutic stock current value and its past values and can show if there is a momentum factor associated with investing in Medivie Therapeutic.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medivie Therapeutic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medivie Therapeutic's short interest history, or implied volatility extrapolated from Medivie Therapeutic options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Medivie Therapeutic Correlation, Medivie Therapeutic Volatility and Medivie Therapeutic Alpha and Beta module to complement your research on Medivie Therapeutic.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Medivie Stock analysis

When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Medivie Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medivie Therapeutic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medivie Therapeutic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...